View the Latest Photos from the ISTH 2022 Congress View the Latest Photos from the ISTH 2022 Congress Susan Diaz / Tuesday, July 12, 2022 0 1273 Article rating: No rating Tuesday, July 12, 2022 Read more
Miss a Session? Access Most ISTH 2022 Presentations On-Demand Miss a Session? Access Most ISTH 2022 Presentations On-Demand Susan Diaz / Tuesday, July 12, 2022 0 1393 Article rating: No rating Tuesday, July 12, 2022 Read more
FRONTIER1: A Phase 1/2 Dose Escalation Study of a Novel Factor VIIIa Mimetic Bispecific Antibody, Mim8, for Evaluation of Safety, Pharmacokinetics and Efficacy FRONTIER1: A Phase 1/2 Dose Escalation Study of a Novel Factor VIIIa Mimetic Bispecific Antibody, Mim8, for Evaluation of Safety, Pharmacokinetics and Efficacy Haemin Go / Monday, July 11, 2022 0 970 Article rating: No rating Monday, July 11, 2022 July 11, 2022 | Pratima Chowdary, M.D., F.R.C.Path., Royal Free Hospital, London, United Kingdom Read more
Von Willebrand Factor–Targeting Thrombolysis to Overcome Tissue Plasminogen Activator Resistance In Vivo Von Willebrand Factor–Targeting Thrombolysis to Overcome Tissue Plasminogen Activator Resistance In Vivo Haemin Go / Monday, July 11, 2022 0 798 Article rating: No rating Monday, July 11, 2022 July 11, 2022 | Coen Maas, Ph.D., University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands Read more
Activation of the Plasma Contact System Triggers the Fat Embolism Syndrome Activation of the Plasma Contact System Triggers the Fat Embolism Syndrome Haemin Go / Monday, July 11, 2022 0 608 Article rating: No rating Monday, July 11, 2022 July 11, 2022 | Sandra Konrath, M.Sc., University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany Read more